| Title: | Antidepressant use and dementia, cognitive measures, and neuroimaging outcomes: A population-based cohort study |
| Journal: | Psychological Medicine |
| Published: | 13 Jul 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42438861/ |
| DOI: | https://doi.org/10.1017/s0033291726104942 |
| URL: | ~Ehttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/7EAC901FED8074434DA18B438C34DDED/S0033291726104942a.pdf/div-class-title-antidepressant-use-and-dementia-cognitive-measures-and-neuroimaging-outcomes-a-population-based-cohort-study-div.pdf~ |
Publication 20297
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Prior observational studies have reported conflicting results regarding whether antidepressant treatment reduces long-term dementia risk, likely due to confounding by indication and reverse causation. We aimed to investigate the association between baseline antidepressant use and incident dementia, incorporating cognitive and neuroimaging outcomes.</p>
METHODS: We conducted a prospective cohort study using UK Biobank participants free of dementia at baseline. Antidepressant use was self-reported at baseline (2006-2010). Incident dementia was identified through linked electronic health records until December 19, 2022. Cox proportional hazards models estimated hazard ratios (HRs) for all-cause dementia, Alzheimer's disease (AD), and vascular dementia (VD), adjusting for sociodemographic, lifestyle, health-related, antidepressant indication factors, and co-medication of other anticholinergics. In subsamples, cognitive performance (n = 57,330) and structural brain imaging (n = 42,276) were examined as intermediate outcomes.</p>
RESULTS: Among 461,464 participants, 33,721 (7.3%) reported baseline antidepressant use. Over a mean follow-up of 13.4 years, 7,922 (1.7%) developed incident dementia. Baseline antidepressant use was associated with higher risks of all-cause dementia (adjusted HR: 1.47, 95% CI 1.36-1.60), AD (1.53, 1.36-1.73), and VD (1.44, 1.23-1.70). Users performed worse on fluid intelligence and prospective memory tasks and showed lower total and gray matter volume, regional reductions in the hippocampal gray matter and basal nucleus, and greater white matter hyperintensity volume.</p>
CONCLUSIONS: Baseline antidepressant use was linked to a higher risk of dementia, poorer cognitive performance, and adverse brain structural changes. These findings underscore the importance of judicious prescribing, regular cognitive monitoring, and consideration of non-pharmacological approaches in clinical care.</p>
15 Keywords
- Aged
- Antidepressive Agents
- Brain
- Cognition
- Cohort Studies
- Dementia
- Female
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Neuroimaging
- Prospective Studies
- UK Biobank
- United Kingdom
13 Authors
- Xin Liu
- Tengfei Lin
- Yiwen Jiang
- Shan Luo
- Shanquan Chen
- Yi Chai
- Zhirong Yang
- Ying Wei
- Huali Wang
- Xia Li
- Yu-Tao Xiang
- Feng Sha
- Jinling Tang
1 Application
| Application ID | Title |
|---|---|
| 80476 | Risk factors and prognosis of common mental disorders |
Enabling scientific discoveries that improve human health